Dr. Barnes is the founding Chief Executive and Scientific Officer of Abcodia Ltd, a company focusing on the development of new tests for the early detection of cancer, with lead product the ROCA Test for ovarian cancer screening. She received her BSc in Pharmacology and PhD in Neuroscience. She has more than 30 years’ experience as an entrepreneur and business leader in small and large healthcare companies, including roles as Chief Scientific Officer at BioWisdom Ltd, and Head of Neuroscience at GlaxoWelcome/GlaxoSmithKline. Dr. Barnes is recognized for her breadth of experience in translational research and development. In the field of early cancer detection, she has experience in regulatory processes, economics, the need to prove clinical benefit, the need to balance that with the potential for over-diagnosis and the opportunity for test development in high risk cohorts.